List Of Tuberculosis Pharmaceutical Products classified according to the Global Fund Quality Assurance Policy

Size: px
Start display at page:

Download "List Of Tuberculosis Pharmaceutical Products classified according to the Global Fund Quality Assurance Policy"

Transcription

1 List Of Tuberculosis Pharmaceutical Products classified according to the Global Fund Quality ssurance Policy Edition: Version 88-06th of pril 2018 The list is an overview of pharmaceutical products subject to the Global Fund Quality ssurance Policy that are listed in National and/or standard treatment guidelines and classified according to the various options (,, and ERP reviewed) defined in the Global Fund Quality ssurance Policy (July 2009, amended in December 20). The list is developed as a tool to assist Principal Recipients (PR) of Global Fund grants to identify the status of finished pharmaceutical products according to the Global Fund Quality ssurance Policy. The pharmaceutical products are classified based on the following information classified product - Listed on prequalification list; classified product - Stringent NDR Registration letter/marketing uthorization; ERP reviewed product- Permitted for time-limited procurement based on advice by the Expert Review Panel (ERP); Please note that the list is not an exhaustive list. PR can procure product(s) not listed in the current list as long as PR demonstrates that the product is compliant with the Global Fund Quality ssurance Policy. The Global Fund list includes the following information: - "Important Notes" for helpful information; -,, and ERP reviewed products; - Period validity of the ERP reviewed products; - "+" means combination product, both fixed-dose combination (co-formulated) and co-packaged product ( i.e. co-blister) - [+]+C means and are in fixed-dose formulation and C is co-packaged YELLOW signifies a new entry; PINK signifies modification of an existing entry. For more information, please look at: Important Notes This List may be used by Principal Recipients of Global Fund grants when considering options with respect to procurement of pharmaceutical products pharmaceutical products subject to the Global Fund Quality ssurance Policy. The list aims at providing countries with information that will assist them in their procurement options. Please note that the list is not designed to be a basis for countries to select medicines to be included in their National Treatment Guidelines or to replace any applicable and legally required procurement processes. The Global Fund requires its grant recipients to comply with applicable procurement laws and provides the list only for the identification of products/manufacturers that comply with the Global Fund s quality assurance policy. It is important to note that there is no strict requirement to procure according to the list, as long as the Principal Recipients can ensure that the product selected is compliant with the Quality ssurance policy criteria. Furthermore, the Principal Recipient should not rely solely on the information provided in the list but should obtain evidence of products compliance with the Quality ssurance policy. For the above reasons, we strongly encourage users to ensure they are using the most recent version on our website when conducting procurement. The Lists will be updated regularly based on evidence received by the Global Fund. Interested parties are invited to supply information and evidence of products meeting the policy criteria on an ongoing basis. For the above reasons, we strongly encourage users to ensure they are using the most recent version on our website when conducting procurement. Edition: Version 88, 06th of pril 2018 List of T drugs classified according to the GF Q Policy 1/21

2 ccording to the Global Fund Q policy, if there are two or more or classified manufacturers available for any given product ND the product is available from these manufacturers (available-means that the manufacturer can supply the selected product within 90 days after receiving the Purchase Order), then such product must be procured from or classified product manufacturers. The PR must notify by writing to the Global Fund Secretariat (Fund Portfolio Manager) and recieve the "No Objection" letter from GF secretariat before procuring any products complying with option " ERP Reviewed". For ease of reference, each "product" has been identified in this list with a unique "Product reference number" (Column ). Please see examples below. Several different dosage forms may be grouped under the same Product Reference Number and therefore will be considered the same type of products when identifying the number of available manufacturers for the application of this policy. These products share the same dosing protocol, target the same population, and there are no fundamental differences among them. For example, within solid forms, some capsules will have same reference number as s while within liquids, oral solution and suspension are grouped together.similarly, the entero coated or dispersible will not share the same reference number as non entero coated or dispersible s. Ref.No Non- International proprietary name Strength Dosage form Supplier/Manufacturer* Global Fund Q Prequalified/ SR Manufacturing site* Country Material Pack XYZ 50mg "Pharma Company " - "Pharmaville" Country mg "Pharma Company " - "Pharmaville" Country 60 The example above shows 2 different variants of the same medicine. ecause the strength is different, it is considered 2 different products (there are two different reference numbers 16 and 17). If the strength had been the same but the dosage form had been different (i.e. and liquid) it would also have been considered two different "products". Ref.No Non- International proprietary name Strength Dosage form Supplier/Manufacturer* Global Fund Q Prequalified/ SR Manufacturing site* Country Material Packaging Pack 25 C 150mg "Pharma Company " - "Pharmaville" Country, bottle, 60 Capsules "Pharma Company " - "Pharmaville" Country ottle, 60, In this second example both products have same reference number (25) because both manufacturers are supplying the same strength and the dosage forms are considered similar as per explanation above. * See below Disclaimer: The Global Fund does not endorse or warrant the fitness of any product on the List for a particular purpose, including in regard of its safety and/or efficacy in the treatment of HIV/IDS, tuberculosis or malaria. In addition, the Global Fund assumes no responsibility for any misstatement or omission from the list and directs Principal Recipients of Global Fund grants to conduct their own independent confirmation that the information on a given product on the list is accurate before relying on it to make a purchase order for that product, and to ensure that any purchase is in compliance with all the requirements of the Global Fund s quality assurance policy. The Global Fund does not warrant or represent that the products listed have obtained regulatory approval for use of treatment of any disease in any particular country of the world, or that their use is otherwise in accordance with the national laws and regulations of any country, including, but not limited to, intellectual property laws. The Global Fund disclaims any and all liability and responsibility for any injury, death, damage or loss of any kind whatsoever that may arise as a result of, or in connection with the procurement, distribution and use of any product included in the list. Edition: Version 88, 06th of pril 2018 List of T drugs classified according to the GF Q Policy 2/21

3 List of or products: If there are two or more or products available, then the product must be procured from one of the or products. Note: if the product intended for selection is not listed in this list, please refer to the List of ERP ( Expert Review Panel) Reviewed Products which are permitted for time limited procurement. Ref.No Global Fund Q SR 1 mikacin ( as sulfate) 500 mg/2ml Injection Cipla Goa Glass vial 2ml mikacin ( as sulfate) 500 mg/2ml Injection for IM/IV use Pharmatex, Italy Fisio Pharma Palomonte Italy Glass Vial x 2ml mikacin 500 mg/2ml Injection, for IM/IV use Medochemie Limassol Cyprus Glass vial, ampoules Pack of, mikacin 500 mg/2ml Injection, for IM/IV use Vianex Vianex S.. - Plant ', ttiki, Greece Greece Glass Vial 1x2ml mikacin ( as sulfate) 500 mg/2ml Injection Pharmathen Hellas S.. Pharmathen S., Pallini ttiki, Greece; DEMO S.. Krioneri ttiki, Greece Greece Glass ampoule 2ml 1, 5 or ampoules per carton 2 moxycillin + Clavulanic acid 250mg : 62.5mg/ 5ml oral susp Glaxo SmithKline. Middlesex UK ottle ml moxycillin + Clavulanic acid 250mg mg/ 5ml oral susp rown & urk UK Micro Labs, Veersandhra, nekal, angalore ml moxycillin + Clavulanic acid 250mg mg/ 5ml oral susp Medreich UK Medreich Virgonagar angalore Glass bottle ml with measure cup 3 moxycillin + Clavulanic acid 125mg mg/ 5ml oral susp Glaxo SmithKline. Middlesex UK ottle ml Edition: Version 88, 06th of pril 2018 List of T drugs classified according to the GF Q Policy 3/21

4 Global Fund Q SR moxycillin + Clavulanic acid 125mg mg/ 5ml oral susp rown & urk UK Micro Labs, Veersandhra, nekal, angalore ml moxycillin + Clavulanic acid 125mg mg/ 5ml oral susp Medochemie, Limassol (Cyprus) No Medochemie, Limassol Cyprus ml 4 moxycillin + Clavulanic acid 250mg+125mg rown & urk UK Micro Labs, Veersandhra, nekal, angalore 8,, 14, 16, 21 moxycillin + Clavulanic acid 250mg+125mg Remedica Limassol Cyprus lu/ lu (2x s in carton box) 5 moxycillin + Clavulanic acid 500mg + 125mg Remedica Limassol Cyprus lu/ lu (2x s in carton box) moxycillin + Clavulanic acid 500mg+125mg rown & urk UK Micro Labs, Veersandhra, nekal, angalore 8,, 14, 16, 21, 50 & s moxycillin + Clavulanic acid 500mg+125mg Medochemie Limassol Cyprus l/pvc 16, 20, moxycillin + Clavulanic acid 500mg+125mg Reig Jofre Toledo Spain ottle 6, 12(2*6), 24(4*6) 500 moxycillin + Clavulanic acid 500mg+125mg Glaxo SmithKline. Middlesex, Worthing UK 14 moxycillin (as trihydrate)+ Clavulanic acid (as potassium) 500mg+125mg potex Inc Toronto Canada ottle 6 moxycillin + Clavulanic acid 875mg + 125mg Medochemie Limassol Cyprus l/pvc 14 moxycillin + Clavulanic acid 875mg + 125mg Reig Jofre Toledo Spain ottle 6, 12(2*6), 24(4*6) 500 moxycillin + Clavulanic acid 875mg + 125mg Glaxo SmithKline. Middlesex UK 14 moxycillin + Clavulanic acid 875mg+125mg rown & urk UK Micro Labs, Veersandhra, nekal, angalore 2x7, 3x7, 5x5, Edition: Version 88, 06th of pril 2018 List of T drugs classified according to the GF Q Policy 4/21

5 Global Fund Q SR moxycillin + Clavulanic acid 875mg+125mg Medreich UK Medreich Virgonagar, angalore PVC/lu blister 2x8(16) 7 edaquiline Fumarate * mg (ase) Janssen Cilag, elgium Recipharm Pharmaservices private ottle Capreomycin powder for korn korn, Illinois US Glass vial 1, 1* Capreomycin powder for King Pharmaceuticals Limited Vianex S.. - Plant C', 16th km Marathonos ve., Pallini, ttiki, Greece Glass vial 1 Capreomycin powder for for IM use Vianex Vianex S.. - Plant C', 16th km Marathonos ve., Pallini, ttiki, Greece Glass vial 1 Capreomycin powder for Hisun Pharmaceutical (Hangzhou) Co Fuyang, Hangzhou City, Zhejiang Province China Glass vial 1 Capreomycin powder for spen Pharmacare Korsten, Port Elizabeth South frica Glass vial 1 Capreomycin Capreomycin, Mumbai () NCPC International Corp., China (People's Republic of) T 211 T316 Macleods Pharmaceutical, Kachigam, Daman North China Pharmaceutical Co, New Preparation ranch Factory, No. 115 Hainan Road, Shijiazhuang Economic & Technological Development Zone, Glass vial 1 China Glass vial vialx Edition: Version 88, 06th of pril 2018 List of T drugs classified according to the GF Q Policy 5/21

6 Capreomycin (sulfate) 9 Clarithromycin 250mg Global Fund Q SR Mylan Laboratories T329 Mylan Laboratories Limited [HSF], Plot No. 14, Sipcot II, Krishnagiri Road, Hosur, Type 1 glass vial x1 Remedica Limassol Cyprus lu/pvc Clarithromycin 250mg Medochemie Limassol Cyprus 14 7 (2*7 s in carton box) Clarithromycin 250mg Micro Labs Hosur, Tamilnadu PVC/PVdC lu 6,7,8,,12,14,16,20,500 Clarithromycin 250mg HEC Pharm GmbH, Sunshine Lake Pharma Co.,. China Clarithromycin 250mg Clarithromycin 500mg Sunshine Lake Pharma Co.,. DongGuan, GuangDong Province China PVC/PVDC/lu strip Remedica Limassol Cyprus lu/pvc Clarithromycin 500mg Medochemie Limassol Cyprus 14 Clarithromycin 500mg Strandhaven UK Essex UK 14 6,, 12,14, 15, 16, 20, 24 7 (2*7 s in carton box) Clarithromycin 500mg Micro Labs Hosur, Tamilnadu lu/pvc 6,7,8,,12,14,16,20,500 Clarithromycin 500mg Clarithromycin 500mg HEC Pharm GmbH, Sunshine Lake Pharma Co.,. Clarithromycin 500mg Mylan Laboratories Sunshine Lake Pharma Co.,. DongGuan, GuangDong Province Waluj, urangabad, Maharashtra China China PVC/PVDC/lu strip, 14, 16, 20, 42, Clofazimine * 50mg Capsule Novartis, Switzerland Sandoz, Kalwe ottle Clofazimine * mg Capsule Novartis, Switzerland Sandoz, Kalwe ottle Edition: Version 88, 06th of pril 2018 List of T drugs classified according to the GF Q Policy 6/21

7 Global Fund Q SR 12 Cycloserine 250 mg Capsule Kachigam, Daman Solan Himachal Pradesh l Strip Cycloserine 250 mg Capsule Dong- Pharmaceutical Co Cycloserine 250 mg Capsule Chao Centre Dong- Pharmaceutical Co Cheonan, Chungcheongnamdo Chao Centre na Republic of Korea lu/lu strip US ottle 40 Cycloserine 250 mg Capsule iocom JSC Stavropol Russia ottle Cycloserine 250 mg Capsule Cipla Verna Salcette, Goa ottle 40 Cycloserine 250 mg Capsule Strides Shasun T306 Strides Shasun, Unit II, RS No 32-34, PIMS Road, Periyakalapet, Puducherry, ottle lu/lu 40x1 Cycloserine 250 mg Capsule Mylan Laboratories T304 Plot No H-12 & H13 MIDC Waluj Industrial rea, urangabad, Maharashtra, ottle ; lu/lu x1; x1 13 Delamanid * 50mg Otsuka Novel Products GmbH, ndersonrecon (UK). 14 Ethambutol mg Labatec Pharma Meyrin, Geneva Ethambutol mg (Former FTOL-(RIEMSER) rzneimittel) Ethambutol mg UK Switzerlan d Kachigam Damam ottle lu/lu strip PVC/lu ottle PVC/clar/PVC /lu blister l/pvc/pvdc blister 50, 300 5x8tab(40) 6x8 tab(48) * 50,, 500 x, 24 x 28; bottle Edition: Version 88, 06th of pril 2018 List of T drugs classified according to the GF Q Policy 7/21

8 15 Ethambutol 250 mg 16 Ethambutol 400 mg (Former FTOL-(RIEMSER) rzneimittel) Cadila Pharmaceuticals Global Fund Q SR Dholka, hmedabad, PVC/lu blister, 500 lu/pvc/pvdc ;, 28; Ethambutol 400 mg Kachigam, Daman ; ottle, 28; Ethambutol 400 mg OlainFarm JSC Olaine Latvia ottle Chikalthana, PVC/PVDC/lu 28,; urangabad blister ; Ethambutol 400 mg Lupin ari, 500, rahmana, Jammu s (J & K) Ethambutol 400 mg Labatec Pharma Meyrin, Geneva Ethambutol 400 mg Svizera Europe V Svizera Labs Pvt, Plot No D16/6 TTC Industrial rea, MIDI, Turbhe, Navi Mumbai, Switzerlan d PVC/lu * ottle ; 28x24, Ethambutol 400 mg (Former FTOL-(RIEMSER) rzneimittel) PVC/lu blister, 500 Ethambutol 400 mg S.C. ntibiotice S. Lasi Romania lupvc 17 Ethambutol 500 mg 18 Ethambutol + Isoniazid 400 mg mg Ethambutol + Isoniazid 400 mg mg 19 Ethambutol + Isoniazid + Rifampicin Ethambutol + Isoniazid +Rifampicin 275 mg+75 mg+150 mg 275mg +75mg +150mg s (Former FTOL-(RIEMSER) rzneimittel) Cadila Pharmaceuticals Kachigam, Daman Dholka, hmedabad, Kachigam, Daman; Oxalis lab, Solan, addi Lupin urangabad 2x 150x PVC/lu blister, 500 lu/pvc/pvdc ; PVC/PVdcV/ lu blister container; lu/pvc/pvdc ottle lu/pvc/pvdc blister, 28;, 28 ;, Edition: Version 88, 06th of pril 2018 List of T drugs classified according to the GF Q Policy 8/21

9 Global Fund Q SR Ethambutol + Isoniazid +Rifampicin 275mg +75mg +150mg Svizera Europe V T192 Svizera Labs Pvt, Plot No D16/6 TTC Industrial rea, MIDI, Turbhe, Navi Mumbai, ottle ; lu/pvc/pvdc x1; 28x24 20 Ethambutol + Isoniazid + Pyrazinamide + Rifampicin 275 mg + 75 mg mg mg Lupin Chikalthana urangabad ; 4, 28;672, 500, Ethambutol + Isoniazid + Pyrazinamide + Rifampicin 275 mg + 75 mg mg mg Sandoz Pty Strides rcolab, angalore; Sandoz, Kalwe, Navi Mumbai; Sandoz, Kolshet, Thane; ; ottle PVC/PE/PVd C/lu blister 30, 60, 120, 240, 672, ; Polypropylen e containers 500,; 500 Ethambutol + Isoniazid + Pyrazinamide + Rifampicin Ethambutol Hydrochloride+ Isoniazid + Pyrazinamide + Rifampicin 275 mg + 75 mg mg mg 275 mg + 75 mg mg mg Micro Labs T223 Kachigam, Daman; Oxalis lab, Solan, addi Kumbalgodu, angalore, Karnataka, container; lu/pvc/pvdc lu/lu strip ottle 500, ;, 28, 24x Ethambutol Hydrochloride+ Isoniazid + Pyrazinamide + Rifampicin 275 mg + 75 mg mg mg Svizera Europe V T193 Svizera Labs Pvt, Plot No D16/6 TTC Industrial rea, MIDI, Turbhe, Navi Mumbai, ottle ; lu/pvc/pvdc x1; 28x24 Ethionamide 125 mg, Mumbai () T314 Kachigam, Daman lu/lu strip Ethionamide 125 mg Dispersible, Mumbai () T333 Kachigam, Daman lu/lu strip 6x5 Ethionamide 125 mg Micro Labs T331 Unit 03, 92 Sipcot Industrial Complex, Hosur, Tamil Nadu ottle lu/pvc- PVdC x1; ;x14 Edition: Version 88, 06th of pril 2018 List of T drugs classified according to the GF Q Policy 9/21

10 21 Ethionamide 250 mg Ethionamide 250mg Global Fund Q SR Kachigam, Daman Oxalis lab, Solan, addi Cipla Patalganga Ethionamide 250mg Lupin urangabad Ethionamide 250mg Micro Labs Hosur, Tamilnadu ; Strip ottle; lu/pvc/pvdc lsiter ottle ; L/L Strip ottle ; PVDC/PVC/L Strip ; ; ; 5x ; 22 Imipenum+Cilastatin 250mg/250mg solution for infusion Fresenius Kabi Runcorn, Cheshire UK Glass vial x 20ml 23 Imipenum+Cilastatin 500mg/500mg Injection Labatec Pharma nfarm Facta Farmaceutici CS Dobfar Greece Italy Italy Glass vials in carton box Imipenum+Cilastatin 500mg/500mg Injection DEMO S Pharmaceutical Industry ttiki Greece Glass vial in carton box 1;;50 Imipenum+Cilastatin 500mg/500mg solution for infusion Fresenius Kabi Runcorn, Cheshire UK Glass vial x 20ml Imipenum+Cilastatin Imipenum+Cilastatin Panpharma 500mg/500mg 500mg/500mg solution for infusion solution for infusion Sun Pharmaceutical Industries 24 Isoniazid 50 mg (Former FTOL-(RIEMSER) rzneimittel) 25 Isoniazid mg PNMEDIC, France Isoniazid mg (Former FTOL-(RIEMSER) rzneimittel) Madhya Pradesh Glass vial x 30ml FCT FRMCEUTICI S.p. Kachigam, Daman Oxalis lab, Solan, addi Isonazid mg Micro Labs Hosur, Tamilnadu Isonazid mg Lupin Chikalthana, urangabad, Isonazid mg Labatec Pharma Meyrin, Geneva Italy Glass vial 20ml 1,, 25 Switzerlan d PVC/clar/PVC /lu blister Container; PVC/PVdc PVC/clar/PVC /lu blister Container l/pvc/pvdc blister PVC/lu ottle, 500 ;, 28, 500 * (), * Edition: Version 88, 06th of pril 2018 List of T drugs classified according to the GF Q Policy /21

11 Global Fund Q SR Isonazid mg S.C. ntibiotice S. Lasi Romania lupvc 26 Isoniazid 200 mg (Former FTOL-(RIEMSER) rzneimittel) 27 Isoniazid 300 mg Kachigam, Daman Oxalis lab, Solan, addi Isoniazid 300 mg Micro Labs Hosur, Tamilnadu PVC/clar/PVC /lu blister Container ; PVC/PVdC/lu Container Isonazid 300mg S.C. ntibiotice S. Lasi Romania lupvc 2x 150x, 500 ;, 28 3x 150x Isonazid 300mg Cadila Pharmaceuticals Dholka, hmedabad PVC-PVDC/lu blister ;,24x28 500, 28 Isoniazid + Rifampicin 30mg+ 60mg Isoniazid + Rifampicin 30mg+ 60mg 29 Isoniazid + Rifampicin 60mg + 60mg Dispersible DispersibleT ablet Dispersible Lupin Kachigam, Daman Chikalthana, urangabad; ari rahmana, Jammu (J&K) Kachigam, Daman container; lu/pvc/pvdc ;, 28 l/l strip 15x6; 14x6 container; lu/pvc/pvdc ;, Isoniazid + Rifampicin 75 mg mg Lupin Chikalthana urangabad ; 15;, 500, Isoniazid + Rifampicin 75 mg mg Sandoz Pty Isoniazid + Rifampicin 75 mg mg Strides rcolab, angalore; Sandoz, Kalwe, Navi Mumbai; Sandoz, Kolshet, Thane Kachigam, Daman; Oxalis lab, Solan, addi ; ottle; lu/pvc/pvdc 30, 60, 120, 240, 28,672, ; 500, ; 500, ;, 28 Edition: Version 88, 06th of pril 2018 List of T drugs classified according to the GF Q Policy 11/21

12 Global Fund Q SR Isoniazid + Rifampicin 75 mg mg Svizera Europe V T189 Svizera Labs Pvt, Plot No D16/6 TTC Industrial rea, MIDI, Turbhe, Navi Mumbai, ottle ; lu/pvc/pvdc x1; 28x24 31 Isoniazid+Rifampicin 150mg+150mg Lupin urangabad $ 32 Isoniazid + Rifampicin 150 mg mg Grouppo Lepetit Isoniazid + Rifampicin Isoniazid + Rifampicin 150 mg mg 150 mg mg nagni 28 Italy 8, 24 Remedica Limassol Cyprus PP/PE ottle (Former FTOL-(RIEMSER) rzneimittel) PVC/lu blister, 500 Isoniazid + Rifampicin 150 mg mg Capsule S.C. ntibiotice S. Lasi Romania lupvc Isoniazid + Rifampicin 150 mg mg 33 Isoniazid + Pyrazinamide+Rifampicin 30 mg+ 150 mg+60mg Dispersible T231 Kachigam, Daman Kachigam, Daman ottle; PVC/PVDC/ lu blister container; lu/pvc/pvdc 1x x,500;, 3x28, 24x28 ;, 28 Isoniazid + Pyrazinamide+Rifampicin 30 mg+ 150 mg+60mg Dispersible Lupin Chikalthana, urangabad, ; ari rahmana, Jammu (J&K), l/l strip 15x6; 14x6 Isoniazid + Pyrazinamide+Rifampicin 50 mg+ 150 mg+75mg Dispersible T309 Unit 2, Plot No 25-27, Survey No 366, Premier Industrial Estate, Kachigam, Daman, Strip lu/lu, ottle, 34 Kanamycin Kanamycin (sulfate) Kanamycin (sulfate) 500mg powder for powder for powder for Panpharma Laboratory Fougeres France Glass vial 50 T213 T212 Unit 2, Plot No 25-27, Survey No 366, Premier Industrial Estate, Kachigam, Daman, Unit 2, Plot No 25-27, Survey No 366, Premier Industrial Estate, Kachigam, Daman, Glass vial ml 1 Glass vial ml 1 Edition: Version 88, 06th of pril 2018 List of T drugs classified according to the GF Q Policy 12/21

13 35 Kanamycin /4ml Levofloxacin mg solution for - Route of administratio n:im Dispersible Global Fund Q SR Meiji Seika Pharma Tokyo Japan Glass ampoule Macleods T326 lock N2 Village Theda, P.O. Lodhimajra, Tehsil addi, District:-Solan Himachal Pradesh pack lu/lu strip pack 36 Levofloxacin 250mg Cipla Goa ottle; lu/pvc 50; * Levofloxacin 250mg Hetero Labs Hetero Labs Limited UNIT- V, TSIIC Formulation SEZ, Sy No. 439, 440, 441 & 458, Polepally Village, Jadcherla Mandal, Mahaboobnagar District, lu/pvc 3*1, 5*1, 7*1, *1,14*1, 50*1, 200*1 Levofloxacin 250mg Micro Labs Hosur, Tamilnadu PVC/lu blister Levofloxacin 250mg Denk Pharma GmbH & Co Rottendorf Pharma GmbH, Ennigerloh, 3, 5, 7, Levofloxacin 250mg potex Inc potex Inc Toronto Canada ottle Levofloxacin 250mg Medochemie Limassol Cyprus Levofloxacin 250mg Levofloxacin HEC Pharm 250mg HEC Pharm GmbH, Solan, Himachal Pradesh, Sunshine Lake Pharma Co.,. 37 Levofloxacin 500mg Cipla Goa China 3,5,7, ox () lu/pvc blister 5's x 20 PVC/PVDC/L U- ottle; lu/pvc Levofloxacin 500mg Micro Labs Hosur, Tamilnadu PVC/lu blister 6's 50; 1* Edition: Version 88, 06th of pril 2018 List of T drugs classified according to the GF Q Policy 13/21

14 Global Fund Q SR Levofloxacin 500mg Denk Pharma GmbH & Co Rottendorf Pharma GmbH, Ennigerloh 5, 7, Levofloxacin 500mg potex Inc potex Inc Toronto Canada ottle Levofloxacin 500mg Medochemie Limassol Cyprus 3,5,7, ox (8x) Levofloxacin 500mg Solan, Himachal Pradesh, lu/pvc blister 5's x 20 Levofloxacin HEC Pharm 500mg HEC Pharm GmbH, Sunshine Lake Pharma Co.,. China PVC/PVDC/L U- 's Levofloxacin 500mg Hetero Labs Hetero Labs Limited UNIT- V, TSIIC Formulation SEZ, Sy No. 439, 440, 441 & 458, Polepally Village, Jadcherla Mandal, Mahaboobnagar District, lu/pvc 1*1, 5*1, 7*1, *1,14*1, 50*1, 500*1 38 Levofloxacin 750mg potex Inc potex Inc Toronto Canada ottle Levofloxacin 750mg Solan, Himachal Pradesh, lu/pvc blister 's x Levofloxacin 750mg Hetero Labs, Hetero Unit V ndra Pradesh 5, 39 Linezolid 600mg Hetero Europe SL Spain Hetero Unit V ndra Pradesh 5, Linezolid 600mg Pharmacia UK Pfizer, Puurs, elgium ottle 1x, 2x, 3x, 5x, 6x 30,60 Edition: Version 88, 06th of pril 2018 List of T drugs classified according to the GF Q Policy 14/21

15 Global Fund Q SR Linezolid 600mg Teva Pharma S.L.U, Zaragoza, Spain Teva Pharmaceutical Works, Debrecen Hungary Linezolid 600mg Cipla, T321 Indore, SEZ, Pithampur, Dist Dhar (M.P.), lu/pvc blister ottle x2 20x1 Linezolid 600mg Hetero Labs, T299 Linezolid 600mg Linezolid 600mg 40 Linezolid mg/5 ml 41 Linezolid 2mg/ml 42 Meropenem Meropenem Granules for Oral Suspension Intra Venous Infusion Intra Venous /Inf Intra Venous Dr.Reddy s Laboratories (UK) Limited s T297 Mahaboob Nagar District, ndhra ulk Pradesh Production Polpharma S. ul.pelplinska 19, Starogard Gdanski, Poland lock No. N2, Village Theda, P.O. Lodhi Majra, Tehsil addi, District Solan, Himachal Pradesh, Poland ottle op/l/pvc/l blister lu/pvc Strip lu/lu Pharmacia UK Pfizer, Puurs, elgium Glass bottle Pharmacia UK Vianex, Greece PNMEDIC, France Fresenius Kabi Norge S Vianex Plant D Patra, xaia FacT FRMCEUTICI S.p., Teramo Norway Greece Italy Infusion bag Glass vial Glass vial 20 s & s units per pack in ; 20; 30; 50; 60; ;, 4x5 5x240ml (66 g per bottle) x240ml (66 g per bottle) 5x300ml x300ml 20x 300ml 1 vial 1x vials 1 vial 1x vials Meropenem Intra Venous DEMO S Pharmaceutical Industry Greece DEMO S Pharmaceutical Industry 43 Moxifloxacin ( as hydrochloride) 400 mg Cipla Patalganga Greece Glass vial ottle; 1 vial 1x vials 30,, ; 5 Moxifloxacin 400mg ayer Schering G ayer Schering G Leverkusen 5 Edition: Version 88, 06th of pril 2018 List of T drugs classified according to the GF Q Policy 15/21

16 Moxifloxacin 400mg Moxifloxacin 400mg Sun Pharmaceutical Industries Global Fund Q SR Kachigam, Damam; Solan, addi MSN Laboratories, Medak District, ndhra Pradesh, lu/lu cold form blister lu/lu strip lu/pvc/pvdc blister 5,, 20 1 x 5, 1 x Moxifloxacin 400mg Hetero Europe SL Hetero Unit V ndra Pradesh 5,7, Moxifloxacin ( as hydrochloride) 400 mg Mylan Laboratories Limited T286 Sinnar, Nashik, Maharashtra, lu/pvc/pvdc blister ottle Moxifloxacin ( as hydrochloride) 400 mg Micro Labs, T263 Hosur, Tamilnadu PVC/PE/PVDC /lu blister; lu/lu blister; ; x ; 30, Moxifloxacin ( as hydrochloride) 400 mg Hetero Labs, T315 Unit 5, Survey No 439, 440, 441 & 458 TSIIC Formulation SEZ, Polepally Village, Jadcherla (M), Mahaboob Nagar District, Telangana, lu/lu x1 44 Ofloxacin 200mg Cipla Patalganga ottle; lu/pvc, 500, ; Ofloxacin 200mg Micro Labs Hosur, Tamilnadu Ofloxacin 200mg Solon Himachal Pradesh Ofloxacin 200mg Remedica Limassol Cyprus 45 Ofloxacin 400mg Cipla Patalganga Ofloxacin 400mg Micro Labs Hosur, Tamilnadu ottle; PV/lu PVC/lu blister PVC/lu blister ottle; lu/pvc ottle; PV/lu,500,, 500, ; Edition: Version 88, 06th of pril 2018 List of T drugs classified according to the GF Q Policy 16/21

17 Global Fund Q SR Ofloxacin 400mg Remedica Limassol Cyprus 46 Para-aminosalicylate sodiam 60% w/w 47 Para-aminosalicylic cid sodiam 4g Delayed Release Granules oral solution Kachigam, Daman Solan, Himachal Pradesh PVC/lu blister container; Sachet,500, OlainFarm JSC - Olaine Latvia ox 25, 300 g; 9.2g Para-minoSalicylic cid 4g Granules Jacobus New Jersey US ox Prothionamide 250mg OlainFarm JSC Olaine Latvia Prothionamide 250mg (Former FTOL-(RIEMSER) rzneimittel) Schiffweiler PVC/L blister 50, Prothionamide 250mg Micro Labs Hosur ; 14; ottle Prothionamide 250mg Lupin Chikalthana, urangabad Pyrazinamide 150mg Dispersible s T307 Solan, Himachal Pradesh triple laminated bag further packed in 50 Pyrazinamide 400 mg Cadila Pharmaceuticals Dholka, hmedabad ;, 28; Pyrazinamide 400 mg Kachigam,Daman Oxalis lab, Solan, addi ottle; lu/pvc/pvdc ;,28 Pyrazinamide 400 mg Micro Labs Hosur, Tamilnadu 51 Pyrazinamide 500 mg Micro Labs Hosur, Tamilnadu Pyrazinamide 500 mg (Former FTOL-(RIEMSER) rzneimittel) container container lu/pvc/pvdc PVC/lu blister, 500 Pyrazinamide 500 mg OlainFarm JSC Olaine Lativia ottle Pyrazinamide 500 mg Labatec Pharma Meyrin, Geneva Pyrazinamide 500 mg Kachigam Damam Oxalis lab, Solan, addi Switzerlan d lu/pvc blister 3 x, x, 3 x 28, 24 x 28; Edition: Version 88, 06th of pril 2018 List of T drugs classified according to the GF Q Policy 17/21

18 Global Fund Q SR Pyrazinamide 500 mg S.C. ntibiotice S. Lasi Romania lupvc 52 Rifabutin 150mg Capsule Lupin - Chikalthana, urangabad 2x 150x ottle 53 Rifapentine 150mg Sanofi ventis, US - T366 Sanofi Sp, nagni Italy 24 (3 x 8's) 54 Rifampicin mg/5ml Rifampicin mg / 5 ml Granule for Syrup Granulate for oral suspension vantis Pharma (Former FTOL-(RIEMSER) rzneimittel) Gruppo Lepanti, nagni Lomapharm, 55 Rifampicin 150 mg Capsule Labatec Pharma Meyrin, Geneva Italy Glass ottle; 120ml Glass bottle ml Switzerlan d PVC/lu *8's Rifampicin 150 mg Capsule vantis Pharma Gruppo Lepanti, nagni Italy Glass ottle; ; Rifampicin 150 mg (Former FTOL-(RIEMSER) rzneimittel) PVC/clar/PVC /lu blister Rifampicin 150 mg Capsule Remedica Limassol Cyprus lu/pvc blister Rifampicin 150 mg Capsule S.C. ntibiotice S. Lasi Romania lupvc, 500 (* caps in carton box) 2x x Rifampicin 150 mg Capsule T259 Kachigam, Daman ottle; lu/lu strip ; * 56 Rifampicin 300 mg Capsule Labatec Pharma Meyrin, Geneva Rifampicin 300 mg Capsule vantis Pharma Rifampicin 300 mg (Former FTOL-(RIEMSER) rzneimittel) Gruppo Lepanti, nagni Switzerlan d Italy PVC/lu Glass ottle; PVC/clar/PVC /lu blister *4's ;, 500 Rifampicin 300 mg Capsule S.C. ntibiotice S. Lasi Romania lupvc 1x x Rifampicin 300 mg Capsule Remedica Limassol Cyprus lu/pvc blister (* caps in carton box) Edition: Version 88, 06th of pril 2018 List of T drugs classified according to the GF Q Policy 18/21

19 Global Fund Q SR 57 Rifampicin 450 mg Capsule vantis Pharma Gruppo Lepanti, nagni Italy Glass ottle; 30; 8 Rifampicin 450 mg (Former FTOL-(RIEMSER) rzneimittel) PVC/clar/PVC /lu blister, Rifampicin 600 mg (Former FTOL-(RIEMSER) rzneimittel) PVC/clar/PVC /lu blister, 500 Rifampicin+Isoniazid 75mg + 50mg Disp Macleods T302 Phase II, Unit II, Plot No , Premier Ind. Estate, Kachigam, Daman (U.T). Oxalis Labs, Vill. Theda, P.O. container pack lu/lu strip pack (), Streptomycin Panpharma Laboratory Fougeres France ottle 50 Streptomycin -IM Reig Jofre Laboratorio Reig Jofré, S.. Madrid. raun Medical, S.. Jaén Spain Glass Vial Streptomycin 1 g (Former FTOL-(RIEMSER) rzneimittel) Panpharma, Fougeres France ottle 1, Edition: Version 88, 06th of pril 2018 List of T drugs classified according to the GF Q Policy 19/21

20 Streptomycin (sulfate) sterile 1 g Global Fund Q SR NCPC International Corp. T296 North China Pharmaceutical Co, New Preparation ranch Factory, No. 115 Hainan Road, Shijiazhuang, Hebei China (People's Republic of) Vial, Type III glass 1x 60 Terizidone 250mg Capsule (Former FTOL-(RIEMSER) rzneimittel) Schiffweiler 50 Terizidone 250mg Capsule s T303 Macleods Pharmaceuticals, Unit 2, Plot No 25-27, Survey No 366, Premier Industrial Estate, Container, Strip, lu/lu x1 * Conditions to be observed before procuring the products: * edaquiline: Procurement of this item is subject to compliance with recommendations (as confirmed by ) concerning management of this item. See relevant guidance at : * Delamanid: Procurement of this item is subject to compliance with recommendations (as confirmed by ) concerning management of this item. See relevant guidance at: * Clofazimine : Procurement of this item is subject to receipt by GDF of named prescriptions from practitioners authorized to prescribe the medicine for this indication and signed Disclaimer for the use of this product End of or products list Edition: Version 88, 06th of pril 2018 List of T drugs classified according to the GF Q Policy 20/21

21 Edition: Version 88-06th of pril 2018 List Of Tuberculosis Pharmaceutical Products classified according to the Global Fund Quality ssurance Policy List of ERP ( Expert Review Panel) Reviewed Products which are permitted for time limited procurement: If there is no or only one or product available ( supply of the product cannot be done within 90 days after the receipt of the Purchase Order by the manufacturer), grant funds may be used to procure a ERP reviewed product eligible for procurement for limited time (12 months) period. The PR must send the notification form (available at to the Global Fund and upon receiving the No Objection letter form the Global Fund, the procurement can proceed. Please note that the QC test of the selected ERP product will be performed by the Global Fund. Ref.N o International Nonproprietary name Strength/ Dose Dosage form Supplier/ Manufacturer(s) Global Fund Q Period Validity for ERP Review Ethambutol mg disp Macleods ERP reviewed Unit II, Plot No Sr. No. 366, Kachigam, Daman pack lu/lu strip pack 6x Cycloserine USP 125mg capsule Macleods ERP reviewed Capreomycin USP 0.5g Injection Macleods ERP reviewed Moxifloxacin mg disp Macleods ERP reviewed End of ERP Reviewed products list Phase II, Unit II, Plot No Sr. No. 366, Premier Ind. Estate, Kachigam, Daman Macleods Pharmaceuticals Phase I, Unit II, Plot No Sr. No. 366, Kachigam, Daman Macleods Pharmaceuticals Phase I, Unit II, Plot No Sr. No. 366, Kachigam, Daman pack strip pack Glass vial ml pack Edition: Version 88, 06th of pril 2018 List of T drugs classified according to the GF Q Policy 21/21

List Of Tuberculosis Pharmaceutical Products classified according to the Global Fund Quality Assurance Policy

List Of Tuberculosis Pharmaceutical Products classified according to the Global Fund Quality Assurance Policy List Of Tuberculosis Pharmaceutical Products classified according to the Global Fund Quality ssurance Policy Edition: Version 89-16th of May 2018 The list is an overview of pharmaceutical products subject

More information

List Of Tuberculosis Pharmaceutical Products classified according to the Global Fund Quality Assurance Policy

List Of Tuberculosis Pharmaceutical Products classified according to the Global Fund Quality Assurance Policy List Of Tuberculosis Pharmaceutical Products classified according to the Global Fund Quality ssurance Policy Edition: Version 95-18th of December 2018 The list is an overview of pharmaceutical products

More information

Quality of 2 nd line medicines for tuberculosis. Ms Lisa Hedman World Health Organization Department of Essential Medicines and Health Products

Quality of 2 nd line medicines for tuberculosis. Ms Lisa Hedman World Health Organization Department of Essential Medicines and Health Products Quality of 2 nd line medicines for tuberculosis Ms Lisa Hedman World Health Organization Department of Essential Medicines and Health Products Case studies in medicines for tuberculosis Outline: Statistics

More information

Moxifloxacin (as hydrochloride) 400 mg Tablets WHOPAR part 6 November 2017 (Hetero Labs Limited), TB 315

Moxifloxacin (as hydrochloride) 400 mg Tablets WHOPAR part 6 November 2017 (Hetero Labs Limited), TB 315 This part reflects the scientific knowledge and the information about this product available at the time of prequalification. Thereafter, updates may have become necessary which are included in parts 1

More information

THE NEW DR-TB NATIONAL POLICY AND STATE OF IMPLEMENTATION

THE NEW DR-TB NATIONAL POLICY AND STATE OF IMPLEMENTATION 1 THE NEW DR-TB NATIONAL POLICY AND STATE OF IMPLEMENTATION Dr. Norbert Ndjeka MD, DHSM (Wits), MMed(Fam Med) (MED), Dip HIV Man (SA) Director Drug-Resistant TB, TB and HIV National Department of Health

More information

I am writing in response to your request for information made under the Freedom of Information Act 2000 in relation to Antibiotics.

I am writing in response to your request for information made under the Freedom of Information Act 2000 in relation to Antibiotics. Ref: FOI/CAD/ID 3459 27 June 2017 Please reply to: FOI Administrator Trust Management Maidstone Hospital Hermitage Lane Maidstone Kent ME16 9QQ Email: mtw-tr.foiadmin@nhs.net Freedom of Information Act

More information

- the details, where possible, of the antibiotic products these companies supply or have supplied.

- the details, where possible, of the antibiotic products these companies supply or have supplied. Under the Freedom of Information Act 2000 please could you provide me with a list of all companies currently supplying antibiotics - or that have supplied antibiotics in the last three years - to Royal

More information

Summary of outcomes from WHO Expert Group Meeting on Drug Susceptibility Testing - PRELIMINARY -

Summary of outcomes from WHO Expert Group Meeting on Drug Susceptibility Testing - PRELIMINARY - Summary of outcomes from WHO Expert Group Meeting on Drug Susceptibility Testing PRELIMINARY 4 th Annual GLI meeting 17 April 2012 Fuad Mirzayev Laboratories, Diagnostics and Drug Resistance unit, Stop

More information

AMOXICILLIN AND CLAVULANIC ACID TABLETS Draft proposal for The International Pharmacopoeia (February 2018)

AMOXICILLIN AND CLAVULANIC ACID TABLETS Draft proposal for The International Pharmacopoeia (February 2018) February 2018 Draft for comment 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 AMOXICILLIN AND CLAVULANIC ACID TABLETS Draft

More information

Session 1: An introduction to the new requirements under the Food and Drug Regulations affecting industry and health care practitioners who compound

Session 1: An introduction to the new requirements under the Food and Drug Regulations affecting industry and health care practitioners who compound Session 1: An introduction to the new requirements under the Food and Drug Regulations affecting industry and health care practitioners who compound veterinary drugs February 13, 2018 Webinar Presentation

More information

Management of MDR and XDR TB Prof. Martin Boeree

Management of MDR and XDR TB Prof. Martin Boeree Management of MDR and XDR TB 1, MD, PhD Associate Professor Consultant Respiratory Medicine Department of Lung Diseases Radboud University Nijmegen Medical Centre TB Referral Hospital Dekkerswald Nijmegen,

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES CONTROL ACT 101 OF 1965 Application Number Holder of

More information

Multidrug-resistant Tuberculosis. Charles L. Daley, MD National Jewish Health Chair, Global GLC, WHO and Stop TB Partnership

Multidrug-resistant Tuberculosis. Charles L. Daley, MD National Jewish Health Chair, Global GLC, WHO and Stop TB Partnership Multidrug-resistant Tuberculosis Charles L. Daley, MD National Jewish Health Chair, Global GLC, WHO and Stop TB Partnership Disclosures World Health Organization Chair, Global GLC Otsuka Chair, Data Monitoring

More information

No /46/2016-PI.I GOVERNMENT OF INDIA MINISTRY OF CHEMICALS & FERTILIZERS DEPARTMENT OF PHARMACEUTICALS

No /46/2016-PI.I GOVERNMENT OF INDIA MINISTRY OF CHEMICALS & FERTILIZERS DEPARTMENT OF PHARMACEUTICALS No. 31015/46/2016-PI.I GOVERNMENT OF INDIA MINISTRY OF CHEMICALS & FERTILIZERS DEPARTMENT OF PHARMACEUTICALS.. A- Wing, Shastri Bhawan, New Delhi 110 001 Subject: Review application of M/s Cipla Ltd. against

More information

United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE

United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT (AT, BE,

More information

Challenges to treat MDR TB

Challenges to treat MDR TB Challenges to treat MDR TB Manfred Danilovits Tartu University Hospital, Estonian NTP Program 2nd European Advanced Course in Clinical Tuberculosis 22-24 September 2014, Amsterdam MDR-TB control; WHO Europe,

More information

TRANSPARENCY COMMITTEE

TRANSPARENCY COMMITTEE The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 29 October 2014 GRANUPAS, gastro-resistant granules 30 sachets with a calibrated measuring spoon (CIP: 34009 278 801

More information

United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS MUTUAL RECOGNITION PROCEDURE

United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS MUTUAL RECOGNITION PROCEDURE United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS MUTUAL RECOGNITION PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT Clavudale

More information

Drug-resistant TB therapy: the future is now

Drug-resistant TB therapy: the future is now Drug-resistant TB therapy: the future is now Gary Maartens Thanks to Francesca Conradie for sharing slides Division of Clinical Pharmacology UNIVERSITY OF CAPE TOWN IYUNIVESITHI YASEKAPA UNIVERSITEIT VAN

More information

Clinical Management : DR-TB

Clinical Management : DR-TB Clinical Management : DR-TB Charoen Chuchottaworn MD., Senior Medical Advisor, Central Chest Institute of Thailand, Department of Medical Services, MoPH. Tuberculosis Classification Drug susceptible TB

More information

Approved Drug Product List - Orange Book Reference Listed Drugs by ANDA Reference Standard List. April 2017 Page 1 of 6

Approved Drug Product List - Orange Book Reference Listed Drugs by ANDA Reference Standard List. April 2017 Page 1 of 6 April 2017 Page 1 of 6 DESCRIPTION This list refers to drug products approved under an Abbreviated New Drug Application (ANDA) that FDA has selected as reference standards and the associated reference

More information

Amoxicillin 875 Mg Twice A Day For Strep Throat

Amoxicillin 875 Mg Twice A Day For Strep Throat Amoxicillin 875 Mg Twice A Day For Strep Throat amoxicillin 500mg 3 times a day for 7 days amoxicillin rx for dental infection amoxicillin 125mg 5ml ulotka amoxicillin 500mg 4 times a day is 500mg of amoxicillin

More information

Multi-Drug and Extensively Drug Resistant Tuberculosis

Multi-Drug and Extensively Drug Resistant Tuberculosis Multi-Drug and Extensively Drug Resistant Tuberculosis Gwen A. Huitt, M.D., M.S. Professor, Department of Medicine Director, Adult Infectious Disease Care Unit National Jewish Health Disclosures None Tuberculosis

More information

Amoxicillin Mg Dosage

Amoxicillin Mg Dosage Amoxicillin 875 125 Mg Dosage amoxicillin 500 mg dosage tooth infection buy amoxicillin online next day delivery amoxicillin 875 mg twice a day uses amoxicillin 500mg twice a day for sinus infection amoxicillin

More information

Freedom of Information Act 2000 Request Reference FoI/16/226 Companies Supplying Antibiotics

Freedom of Information Act 2000 Request Reference FoI/16/226 Companies Supplying Antibiotics Freedom of Information Act 2000 Request Reference FoI/16/226 Companies Supplying Antibiotics Request details Under the Freedom of Information Act 2000 please could you provide me with the following: 1.

More information

Rate In Rs.Ps (ED Included. Tax Extra) Sl No Name Of The Product Pack. Scheduled And Non-Scheduled Formulations Capsules

Rate In Rs.Ps (ED Included. Tax Extra) Sl No Name Of The Product Pack. Scheduled And Non-Scheduled Formulations Capsules KAPL list of products applicable for Institutional/Hospital supplies under Pharmaceuticals Purchase Policy (PPP) issued by Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt. of India

More information

What s New NPPA has fixed/revised ceiling prices/retail Prices of 65 formulations under Drugs

What s New NPPA has fixed/revised ceiling prices/retail Prices of 65 formulations under Drugs What s New 8.2.207 NPPA has fixed/revised ceiling prices/retail Prices of 65 formulations under Drugs (Prices Control) Order, 203 NPPA has fixed/revised ceiling prices/retail Prices of 65 scheduled formulations

More information

Amoxicillin 500 Mg Dosage For Dogs

Amoxicillin 500 Mg Dosage For Dogs Amoxicillin 500 Mg Dosage For Dogs amoxicillin cost canada amoxicillin 500mg twice a day for 7 days amoxicillin 500 dosage amoxicillin 250mg 5ml dosage for babies amoxicillin 90 mg kg day amoxicillin mg

More information

New drugs and regimens for treatment of drug-sensitive TB (DS-TB) Patrick

New drugs and regimens for treatment of drug-sensitive TB (DS-TB) Patrick New drugs and regimens for treatment of drug-sensitive TB (DS-TB) Patrick Phillips Patrick.Phillips@ucsf.edu @PPJPhillips Outline Overview of regimen development strategies 1-3 year horizon: Ongoing phase

More information

3 party manufacturing PRODUCT LIST. Category : ANTI BIOTIC

3 party manufacturing PRODUCT LIST. Category : ANTI BIOTIC rd 3 party manufacturing PRODUCT LIST Category : ANTI BIOTIC ANTI BIOTIC SR.NO. COMPOSTION DRUG/FOOD DOSAGE PACKING 1 Amikacin Sulphate IP 500mg/2ml DRUG LIQUID INJ. VIAL 2 Amoxicillin 200mg & Clavulanic

More information

Multidrug resistant tuberculosis. Where next? Professor Peter D O Davies (Liverpool)

Multidrug resistant tuberculosis. Where next? Professor Peter D O Davies (Liverpool) Multidrug resistant tuberculosis. Where next? Professor Peter D O Davies (Liverpool) DOTS + and LTBI New drugs for TB and the challenge of resistance talk plan 1. Epidemiology 2. Treatment 3. The MDRTB

More information

Quality ID #66: Appropriate Testing for Children with Pharyngitis National Quality Strategy Domain: Efficiency and Cost Reduction

Quality ID #66: Appropriate Testing for Children with Pharyngitis National Quality Strategy Domain: Efficiency and Cost Reduction Quality ID #66: Appropriate Testing for Children with Pharyngitis National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process

More information

United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE

United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT Advantage

More information

Public Assessment Report. Scientific discussion. Xiflodrop 5 mg/ml eye drops, solution. Moxifloxacin hydrochloride DK/H/2221/001/DC

Public Assessment Report. Scientific discussion. Xiflodrop 5 mg/ml eye drops, solution. Moxifloxacin hydrochloride DK/H/2221/001/DC Public Assessment Report Scientific discussion Xiflodrop 5 mg/ml eye drops, solution Moxifloxacin hydrochloride DK/H/2221/001/DC This module reflects the scientific discussion for the approval of Xiflodrop.

More information

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority Quality ID #66: Appropriate Testing for Children with Pharyngitis National Quality Strategy Domain: Efficiency and Cost Reduction Meaningful Measure Area: Appropriate Use of Healthcare 2019 COLLECTION

More information

MDR treatment. Shanghai, May 2012 Arnaud Trébucq The Union

MDR treatment. Shanghai, May 2012 Arnaud Trébucq The Union MDR treatment Shanghai, May 2012 Arnaud Trébucq The Union Why to diagnose MDR-TB? Outcome of SS+ new MDR-TB cases, treated with First Line TB (FLD) drugs Setting Success Died Fail LFFU Transf. Corea 20(56)

More information

United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS MUTUAL RECOGNITION PROCEDURE

United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS MUTUAL RECOGNITION PROCEDURE United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS MUTUAL RECOGNITION PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT Clavudale

More information

FRENCH AGENCY FOR VETERINARY MEDICINAL PRODUCTS La Haute Marche Javené BP FOUGERES cedex FRANCE

FRENCH AGENCY FOR VETERINARY MEDICINAL PRODUCTS La Haute Marche Javené BP FOUGERES cedex FRANCE FRENCH AGENCY FOR VETERINARY MEDICINAL PRODUCTS La Haute Marche Javené BP 90203 35302 FOUGERES cedex FRANCE DECENTRALISED PROCEDURE FOR A VETERINARY MEDICINAL PRODUCT Zodon 25 mg/ml oral solution for cats

More information

DR-TB PATIENT IDENTITY CARD

DR-TB PATIENT IDENTITY CARD Ministry of Health Community Development Gender Elderly and Children National Tuberculosis and Leprosy Programme DR-TB 02 DR-TB Treatment Unit: DR-TB PATIENT IDENTITY CARD DR-TB Reg. Number: Date of registration:

More information

Treatment of Multidrug-resistant Tuberculosis (MDR-TB)

Treatment of Multidrug-resistant Tuberculosis (MDR-TB) Treatment of Multidrug-resistant Tuberculosis (MDR-TB) 2006 2008 2011 2013 2014 2016 2019 Charles L. Daley, MD National Jewish Health University of Colorado Disclosures Research grant Insmed: Phase II

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965 Application Number Holder of registration

More information

ANTIBIOTICS. Orbit s ANTIBIOTICS. Portfolio

ANTIBIOTICS. Orbit s ANTIBIOTICS. Portfolio ANTIBIOTICS Orbit s ANTIBIOTICS Portfolio ANTIBIOTICS Antibiotics (from ancient Greek αντιβιοτικά, antibiotiká), also called antibacterials, are a type of antimicrobial drug used in the treatment and prevention

More information

Scientific Discussion post-authorisation update for Rheumocam extension X/007

Scientific Discussion post-authorisation update for Rheumocam extension X/007 5 May 2011 EMA/170257/2011 Veterinary Medicines and Product Data Management Scientific Discussion post-authorisation update for Rheumocam extension X/007 Scope of extension: addition of 20 mg/ml solution

More information

MDR/XDR TB. Barbara Seaworth, MD, FIDSA, FACP October 27, TB Intensive October 24 27, 2017 San Antonio, TX

MDR/XDR TB. Barbara Seaworth, MD, FIDSA, FACP October 27, TB Intensive October 24 27, 2017 San Antonio, TX MDR/XDR TB Barbara Seaworth, MD, FIDSA, FACP October 27, 2017 TB Intensive October 24 27, 2017 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Barbara Seaworth, MD, FIDSA, FACP, has the following disclosures

More information

Dosing Your Cat with Azithromycin Pediatric Suspension. By Lorraine Shelton

Dosing Your Cat with Azithromycin Pediatric Suspension. By Lorraine Shelton Dosing Your Cat with Azithromycin Pediatric Suspension By Lorraine Shelton To join a community of cat fanciers and health professionals interested in cattery related health issues, visit http://groups.yahoo.com/group/fanciershealth

More information

Is Amoxicillin 500 Mg Good For Strep Throat

Is Amoxicillin 500 Mg Good For Strep Throat Is Amoxicillin 500 Mg Good For Strep Throat amoxicillin 250 mg dosage for dogs amoxicillin 1000 mg dosage amoxicillin 500mg dosage ear infection amoxicillin 500mg dosage for cats amoxicillin trihydrate

More information

Public Assessment Report Scientific discussion

Public Assessment Report Scientific discussion Public Assessment Report Scientific discussion SE/H/1397/01-05/DC Ramipril/Amlodipine Sandoz (ramipril/amlodipine) Applicant: Sandoz A/S This module reflects the scientific discussion for the approval

More information

Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate

Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate Annex I List of the names, pharmaceutical form, strength of the veterinary medicinal product, animal species, route of administration, applicant in the Member States Member State EU/EEA Applicant Name

More information

Treatment of Drug Resistant TB

Treatment of Drug Resistant TB Treatment of Drug Resistant TB Diana M. Nilsen RN, MD Bureau of TB Control New York City Department of Health & Mental Hygiene Objectives Definition of other drug resistant (ODR), multiple drug resistant

More information

MANUFACTURING PROBLEMS AS OF 22nd June 2018

MANUFACTURING PROBLEMS AS OF 22nd June 2018 3 MANUFACTURING PROBLEMS AS OF 22nd June 2018 If you know of any stock Issues that are not on this list please get in touch at ahope@nhs.net The information contained in this bulletin is based on information

More information

OIE global strategy for rabies control, including regional vaccine banks

OIE global strategy for rabies control, including regional vaccine banks Inception meeting of the OIE/JTF Project for Controlling Zoonoses in Asia under the One Health Concept OIE global strategy for rabies control, including regional vaccine banks Tokyo, Japan 19-20 December

More information

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix O 3 December 2014 Final version Commissioned

More information

Technical Requirements for Pharmaceuticals. Experience with submissions of dossiers

Technical Requirements for Pharmaceuticals. Experience with submissions of dossiers Technical Requirements for Pharmaceuticals. Experience with submissions of dossiers Henrik K.Nielsen Technical Specialist Essential Medicines Unit - Medicines and Nutrition Centre UNICEF SUPPLIER MEETING

More information

International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access.

International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access. I J A P B International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access. ISSN: 2454-8375 COMPARISON OF ANTIMICROBIAL ACTIVITY AND MIC OF BRANDED

More information

OIE Collaborating Centres Reports Activities

OIE Collaborating Centres Reports Activities OIE Collaborating Centres Reports Activities Activities in 2017 This report has been submitted : 2018-01-13 02:04:00 Title of collaborating centre: Diagnosis and Vaccine Evaluation in the Address of Collaborating

More information

Creating a global community for clinical drug repurposing and development. Leonard Sacks Center for drug evaluation and research FDA

Creating a global community for clinical drug repurposing and development. Leonard Sacks Center for drug evaluation and research FDA Creating a global community for clinical drug repurposing and development Leonard Sacks Center for drug evaluation and research FDA Neglected tropical diseases 1) Repurposing and developing new drugs 2)

More information

American Veterinary Medical Association

American Veterinary Medical Association AVMA American Veterinary Medical Association Governmental Relations Division 1910 Sunderland Place, NW Washington, DC 20036-1642 phone 202.789.0007 800.321.1473 fax 202.842.4360 AVMA Headquarters 1931

More information

Compounded Ophthalmic Formulations

Compounded Ophthalmic Formulations Compounded Ophthalmic Formulations Pricing is updated as of April 2018 and may be subject to change PCAB-ACCREDITED 503A PHARMACY PATIENT SPECIFIC Injectable Formulations Dropless Formulations Concentration

More information

Studies on Antimicrobial Consumption in a Tertiary Care Private Hospital, India

Studies on Antimicrobial Consumption in a Tertiary Care Private Hospital, India Human Journals Research Article April 2016 Vol.:6, Issue:1 All rights are reserved by Zarine Khety et al. Studies on Antimicrobial Consumption in a Tertiary Care Private Hospital, India Keywords: Drug

More information

Treatment for NTM: when how.and what next? Pr Claire Andréjak Respiratory and ICU Department University hospital, Amiens, France

Treatment for NTM: when how.and what next? Pr Claire Andréjak Respiratory and ICU Department University hospital, Amiens, France Treatment for NTM: when how.and what next? Pr Claire Andréjak Respiratory and ICU Department University hospital, Amiens, France First step = To diagnose NTM disease One NTM positive sample NTM disease

More information

Amoxicillin 500 teva. Call or

Amoxicillin 500 teva. Call or Amoxicillin 500 teva Copyright 2001. All Rights Reserved Call 1.800.430.5485 or Email: slipgriproducts@earthlink.net Amoxicillin 500 teva FASS.se - läkemedelsinformation för vårdpersonal, patienter och

More information

Should you have any questions, please contact Edith Chang, Ph.D., Senior Scientific Liaison ( or

Should you have any questions, please contact Edith Chang, Ph.D., Senior Scientific Liaison ( or Amlodipine and Tablets Type of Posting Posting Date Targeted Official Date Notice of Intent to Revise 26 Oct 2018 To Be Determined, Revision Bulletin Expert Committee Chemical Medicines Monographs 2 In

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #65 (NQF 0069): Appropriate Treatment for Children with Upper Respiratory Infection (URI) National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS FOR INDIVIDUAL MEASURES:

More information

B. PACKAGE LEAFLET 1

B. PACKAGE LEAFLET 1 B. PACKAGE LEAFLET 1 PACKAGE LEAFLET NICILAN 400 mg/100 mg tablets for dogs 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH

More information

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority Quality ID #65 (NQF 0069): Appropriate Treatment for Children with Upper Respiratory Infection (URI) National Quality Strategy Domain: Efficiency and Cost Reduction Meaningful Measure Area: Appropriate

More information

TB Intensive Houston, Texas. Multi-Drug Resistant (MDR) TB Barbara Seaworth, MD

TB Intensive Houston, Texas. Multi-Drug Resistant (MDR) TB Barbara Seaworth, MD TB Intensive Houston, Texas November 10-12, 12 2009 Multi-Drug Resistant (MDR) TB Barbara Seaworth, MD November 12, 2009 Multi-Drug Resistant (MDR) TB Updates November 12, 2009 Barbara J. Seaworth Professor

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES IN JUNE 2015 BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT

More information

MEDICATIONS MEXICO S DE R.L. DE C.V. Agrifen Acetaminophen Chlorpheniramine 40 # Amikacin Generic 500 mg 2ml 2 ampoules #

MEDICATIONS MEXICO S DE R.L. DE C.V. Agrifen Acetaminophen Chlorpheniramine 40 # Amikacin Generic 500 mg 2ml 2 ampoules # Agrifen Acetaminophen Chlorpheniramine 40 $10 tabs Amikacin Generic 500 mg 2ml 2 ampoules $11 inyectable Amoxil Amoxicillin 500 mg 12 Caps $20 Amoxil Amoxicillin Generic 500 mg 12 Caps $13 Amoxil Amoxicillin

More information

European Medicines Agency role and experience on antimicrobial resistance

European Medicines Agency role and experience on antimicrobial resistance European Medicines Agency role and experience on antimicrobial resistance Regional Training Workshop on Antimicrobial Resistance (AMR) Responding to the global challenge of AMR threats: toward a one health

More information

Clinical Policy: Linezolid (Zyvox) Reference Number: CP.PMN.27 Effective Date: Last Review Date: Line of Business: HIM*, Medicaid

Clinical Policy: Linezolid (Zyvox) Reference Number: CP.PMN.27 Effective Date: Last Review Date: Line of Business: HIM*, Medicaid Clinical Policy: (Zyvox) Reference Number: CP.PMN.27 Effective Date: 09.01.06 Last Review Date: 02.19 Line of Business: HIM*, Medicaid Coding Implications Revision Log See Important Reminder at the end

More information

MOXIFLOXACIN HYDROCHLORIDE (MOXIFLOXACINI HYDROCHLORIDUM) Draft proposal for The International Pharmacopoeia. (January 2018)

MOXIFLOXACIN HYDROCHLORIDE (MOXIFLOXACINI HYDROCHLORIDUM) Draft proposal for The International Pharmacopoeia. (January 2018) January 2018 DRAFT FOR COMMENT 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 MOXIFLOXACIN HYDROCHLORIDE (MOXIFLOXACINI HYDROCHLORIDUM) Draft proposal

More information

Compounded Ophthalmic Formulations

Compounded Ophthalmic Formulations Compounded Ophthalmic Formulations Pricing is updated as of February 2018 and may be subject to change PCAB-ACCREDITED 503A PHARMACY PATIENT SPECIFIC Topical Formulations (Con't) Simple Drops Formulations

More information

United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE

United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT Enrobactin

More information

PROFESSIONAL PRACTICE STANDARD

PROFESSIONAL PRACTICE STANDARD PROFESSIONAL PRACTICE STANDARD Dispensing Drugs TBD Introduction Under the Veterinarians Act and Regulations, veterinarians licensed by the College of Veterinarians of Ontario are authorized to engage

More information

Lot # Exp. Date Product Description / Strength Bottle Size NDC. 23X017 11/2018 Amlodipine and Valsartan Tablets 5 mg/160 mg 90 Count

Lot # Exp. Date Product Description / Strength Bottle Size NDC. 23X017 11/2018 Amlodipine and Valsartan Tablets 5 mg/160 mg 90 Count Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of All Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/ Hydrochlorothiazide Combination Tablets That Are Within Expiry November

More information

+91-8071676073 Grapple Life Sciences Private Limited http://www.grapplelifesciences.com/ Our organization is engaged in the supplying, wholesaling, trading and service providing of Pharmaceutical Medicine.

More information

Treatment of MDR/XDR-TB. Short course chemotherapy for MDR-TB: practical issues. CHIANG Chen-Yuan MD, MPH, DrPhilos

Treatment of MDR/XDR-TB. Short course chemotherapy for MDR-TB: practical issues. CHIANG Chen-Yuan MD, MPH, DrPhilos Treatment of MDR/XDR-TB Short course chemotherapy for MDR-TB: practical issues CHIANG Chen-Yuan MD, MPH, DrPhilos Treatment strategies for MDR-TB Standardized treatment: drug resistance survey data from

More information

AMR Industry Alliance Antibiotic Discharge Targets

AMR Industry Alliance Antibiotic Discharge Targets AMR Industry Alliance Antibiotic Discharge Targets List of Predicted No-Effect Concentrations (PNECs) The members of the AMR Industry Alliance have developed a unified approach to establishing discharge

More information

How do people obtain antibiotics in European countries: an overview

How do people obtain antibiotics in European countries: an overview How do people obtain antibiotics in European countries: an overview Dominique L. Monnet, Programme Coordinator Senior Expert, Scientific Advice Unit & the National Antimicrobial Resistance Focal Points

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)

More information

Guideline on quality data requirements for veterinary medicinal products intended for minor use or minor species (MUMS)/limited market

Guideline on quality data requirements for veterinary medicinal products intended for minor use or minor species (MUMS)/limited market 8 December 2016 EMA/CVMP/QWP/128710/2004-Rev.1 Committee for Medicinal Products for Veterinary Use (CVMP) Guideline on quality data requirements for veterinary medicinal products intended for minor use

More information

Drug resistant TB: The role of the laboratory

Drug resistant TB: The role of the laboratory Drug resistant TB: The role of the laboratory 26 Oct 2012 Andrew Whitelaw NHSLS / UCT TB lab functions: Outline Resistance testing Genotypic Phenotypic Which tests are done when, and why Reporting of

More information

RESEARCH ETHICS UCD. Use of Animals for Research & Teaching POLICY. Version: 5

RESEARCH ETHICS UCD. Use of Animals for Research & Teaching POLICY. Version: 5 Use of Animals for Research & Teaching POLICY Version: 5 TABLE OF CONTENTS 1. INTRODUCTION..3 2. PURPOSE & SCOPE...3 3. STATUTORY REQUIREMENTS...3 4. INSTITUTIONAL ETHICAL REQUIREMENT.4 5. CORE PRINCIPLES

More information

Fiprotec 50 mg Spot On Solution for Cats

Fiprotec 50 mg Spot On Solution for Cats College ter Beoordeling van Geneesmiddelen / Medicines Evaluation Board Graadt van Roggenweg 500 3531 AH Utrecht The Netherlands DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY

More information

In Vitro Activities of Linezolid against Clinical Isolates of ACCEPTED

In Vitro Activities of Linezolid against Clinical Isolates of ACCEPTED AAC Accepts, published online ahead of print on April 00 Antimicrob. Agents Chemother. doi:./aac.001-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

European poultry industry trends

European poultry industry trends European poultry industry trends November 5 th 2014, County Monaghan Dr. Aline Veauthier & Prof. Dr. H.-W. Windhorst (WING, University of Vechta) 1 Agenda The European Chicken Meat Market - The global

More information

PRODUCT-LIST KENVISH HEALTHCARE

PRODUCT-LIST KENVISH HEALTHCARE PRODUCT-LIST TABLETS SR. PRODUCT COMPOSITION PACK PKING 1 Exopan-40 PANTAPRAZOLE 40 MG 2 Exopan-D PANTAPRAZOLE 40 MG+DOMPERIDONE 10 MG 3 Kenvizole-20 RABEPRAZOLE 20 MG 4 Kenvizole-D RABEPRAZOLE 20 MG+DOMPERIDONE

More information

https://www.indiamart.com/healthbiotech/

https://www.indiamart.com/healthbiotech/ +91-8079454100 Health Biotech Limited https://www.indiamart.com/healthbiotech/ The top most leading manufacturing company offers best quality range of broad portfolio of finished Pharmaceutical Formulations.

More information

Clinical Policy: Linezolid (Zyvox) Reference Number: CP.PMN.27 Effective Date: Last Review Date: Line of Business: Oregon Health Plan

Clinical Policy: Linezolid (Zyvox) Reference Number: CP.PMN.27 Effective Date: Last Review Date: Line of Business: Oregon Health Plan Clinical Policy: (Zyvox) Reference Number: CP.PMN.27 Effective Date: 07.01.18 Last Review Date: 05.18 Line of Business: Oregon Health Plan Revision Log See Important Reminder at the end of this policy

More information

Irish Medicines Board

Irish Medicines Board Irish Medicines Board (Reference Member State) DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT Zeronil 50 mg Spot-on Solution for cats CMD(v)/TEM/003-00

More information

LABELLING AND PACKAGE LEAFLET

LABELLING AND PACKAGE LEAFLET LABELLING AND PACKAGE LEAFLET 1 A. LABELLING 2 PARTICULARS TO APPEAR ON THE OUTER PACKAGE CARTON BOX 1. NAME OF THE VETERINARY MEDICINAL PRODUCT MILTEFORAN 20 mg/ml oral solution for dogs miltefosine 2.

More information

TB Grand Rounds. MDR-TB: Management of Adverse Drug Reactions. Reynard J. McDonald, M.D. September 18, Patient History

TB Grand Rounds. MDR-TB: Management of Adverse Drug Reactions. Reynard J. McDonald, M.D. September 18, Patient History TB Grand Rounds MDR-TB: Management of Adverse Drug Reactions Reynard J. McDonald, M.D. September 18, 2007 Patient History This 30 y/o H/M was born in Ecuador and immigrated to the US in 2001 On 11-22-05

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Reference Number: CP.HNMC.24 Effective Date: 07.01.17 Last Review Date: 02.18 Line of Business: Medicaid - HNMC Revision Log See Important Reminder at the end of this policy for important

More information

SECTION 3A. Section 3A Criteria for Optional Special Authorization of Select Drug Products

SECTION 3A. Section 3A Criteria for Optional Special Authorization of Select Drug Products SECTION 3A Criteria for Optional Special Authorization of Select Drug Products Section 3A Criteria for Optional Special Authorization of Select Drug Products CRITERIA FOR OPTIONAL SPECIAL AUTHORIZATION

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Reference Number: CP.HNMC.04 Effective Date: 07.01.17 Last Review Date: 02.18 Line of Business: Medicaid - HNMC Revision Log See Important Reminder at the end of this policy for important

More information

- { PAGE } - GOVERNMENT OF RAJASTHAN DIRECTORATE MEDICAL, HEALTH F.W. SERVICES RAJASTHAN, JAIPUR

- { PAGE } - GOVERNMENT OF RAJASTHAN DIRECTORATE MEDICAL, HEALTH F.W. SERVICES RAJASTHAN, JAIPUR Tender Catelogue for Part-A (Drugs & Medicines) Section-B (Harmons and Antihormones, Antiparkinsonism drugs, Drugs affecting the Blood, Blood Products and Plasma Substitutes, Cardiovascular drugs, Dermatological

More information

DEPOSEL Slow Release Selenium Injection for Cattle and Sheep

DEPOSEL Slow Release Selenium Injection for Cattle and Sheep Date of change: 21 October 2004 Page: 1 of 9 Carton (front panel). POISON KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY DEPOSEL Slow Release Selenium Injection for Cattle and Sheep Active ingredient:

More information

Tuberculosis in 2017: Searching for new solutions in the face of new challenges

Tuberculosis in 2017: Searching for new solutions in the face of new challenges Tuberculosis in 2017: Searching for new solutions in the face of new challenges 6th TB Symposium Ministry of Health of the Republic of Belarus, Republican Scientific and Practical Center for Pulmonology

More information

Practical. Walk through New Survival Guide

Practical. Walk through New Survival Guide Many faces of TB: Drug resistant it ttbs Survival lgid Guide v3 P B L Ch G Sh t L T P. Barry, L. Chen, G. Schecter, L. True Curry International TB Center/CTCA April 20, 2016 Real case Practical Walk through

More information

STATE OF THE GLOBAL PET FOOD RETAIL

STATE OF THE GLOBAL PET FOOD RETAIL STATE OF THE GLOBAL PET FOOD RETAIL CURRENT TRENDS AND GROWTH OPPORTUNITIES PFAC, VANCOUVER, NOVEMBER 8, 2012 GLOBAL UPDATE ON PET CARE: GROWTH IN 2012 AND BEYOND 2 FASTEST GROWING PRODUCT CATEGORIES AND

More information